(Q54568641)

1 June 2018

title

Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells. (English)

1 reference

1 June 2018

1 reference

1

1 reference

1 June 2018

Nicoletta Bianchi

2

1 reference

1 June 2018

Monica Borgatti

3

1 reference

1 June 2018

Ilaria Lampronti

4

1 reference

1 June 2018

Roberto Gambari

7

1 reference

1 June 2018

author name string

Francesco Massei

5

1 reference

1 June 2018

Claudio Favre

6

1 reference

1 June 2018

publication date

5 December 2006

1 reference

1 June 2018

published in

Acta Haematologica

1 reference

1 June 2018

volume

117

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

168-176

1 reference

1 June 2018

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease

cites work

1 reference

Fetal hemoglobin levels in adults

21 January 2018

1 reference

Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia.

21 January 2018

1 reference

21 January 2018

Fetal gene reactivation.

1 reference

Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells

21 January 2018

1 reference

Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin

21 January 2018

1 reference

The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells

21 January 2018

1 reference

Induction of erythroid differentiation of human K562 cells by cisplatin analogs

21 January 2018

1 reference

Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine

21 January 2018

1 reference

Sirolimus: its discovery, biological properties, and mechanism of action

21 January 2018

1 reference

Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.

21 January 2018

1 reference

Rapamycin in transplantation: a review of the evidence

21 January 2018

1 reference

Experience with everolimus

21 January 2018

1 reference

Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation

21 January 2018

1 reference

Effect of rifampin on apparent clearance of everolimus

21 January 2018

1 reference

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

21 January 2018

1 reference

Early clinical experience with a novel rapamycin derivative

21 January 2018

1 reference

Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications

21 January 2018

1 reference

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine

21 January 2018

1 reference

Increase in hemoglobin concentration during therapy with hydroxyurea in Cooley's anemia.

21 January 2018

1 reference

Blood concentrations of everolimus are markedly increased by ketoconazole

21 January 2018

1 reference

The role of therapeutic monitoring of everolimus in solid organ transplantation

21 January 2018

1 reference

Simultaneous measurement of sirolimus and everolimus in whole blood by HPLC with ultraviolet detection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000097465

1 reference

1 June 2018

PubMed ID

17148936

1 reference

1 June 2018